Unmet Needs and Clinical Considerations for HER2+ NSCLC

Key Takeaways

• Effective therapies that penetrate the blood-brain barrier and target resistant tumor cells are needed in lung cancer brain metastases management.
• Current treatments often provide limited survival benefits and significant side effects, highlighting the need for improved therapeutic options.
• Future research opportunities include novel targeted therapies, immunotherapies, and combination approaches to enhance patient outcomes.
• Improved diagnostic tools are necessary for earlier and more accurate identification of brain metastases, enabling timely and personalized treatment strategies.